Search filters

List of works by Afschin Gandjour

A 'centres of excellence' approach in health care: points for and against

scientific article published on 01 January 2002

A model to optimize investments in health technologies, quality of care and research

article

A model to predict the cost-effectiveness of disease management programs

scientific article

A model to transfer trial-based pharmacoeconomic analyses to clinical practice

scientific article published on 01 February 2011

A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness

scientific article published in March 2007

A new prize system for drug innovation

scientific article

A payer's perspective on the cost effectiveness of gastric bypass surgery

scientific article published on 01 November 2009

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency

scientific article published on 23 March 2020

A simulation model to estimate cost-offsets for a disease-management program for chronic kidney disease

scientific article published on 29 November 2014

A theoretical and empirical investigation into the willingness-to-pay function for new innovative drugs by Germany's health technology assessment agency (IQWiG).

scientific article

Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

scientific article published on 30 December 2012

Aging diseases - do they prevent preventive health care from saving costs?

article

An evidence-based disease-management program for patients with diabetic nephropathy.

scientific article published on July 2003

An evidence-based evaluation of quality and efficiency indicators

scientific article

Applying GRADE Criteria to Clinical Inputs to Cost-Effectiveness Modeling Studies

scientific article published on 01 August 2018

Appropriateness of invasive cardiovascular interventions in German hospitals (2000–2001): an evaluation using the RAND appropriateness criteria ⬇️

scientific article published on October 1, 2003

Assessing the value of a future study

scientific article published on 01 January 2008

At what time is a reduction of medical under- or overtreatment sensible? Treatment of acute depression as an example

scientific article published in April 2004

Autonomy, Coercion, and Public Healthcare Guarantees: The Uptake of Sofosbuvir in Germany

scientific article published on 01 January 2021

Avoiding research waste through cost-effectiveness analysis: the example of medication adherence-enhancing interventions

scientific article published on 9 June 2014

Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe.

scientific article

Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases

scientific article published on 27 November 2017

Burden-of-disease estimates

scientific article published on 01 January 2003

Capturing disutility from waiting time

scientific article published on 01 April 2014

Caregiversʼ Quality of Life and Economic Evaluations

scientific article published on September 1, 2012

Changing the organization of health care

Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany".

scientific article published on 6 February 2018

Comment on: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines"

scientific article published on 01 December 2014

Comment on: "Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation".

scientific article

Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy"

scientific article published on 01 September 2015

Comment on: "The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review"

scientific article published on 01 December 2016

Comment on: "The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011".

scientific article published on 25 February 2016

Comment on: "impact and cost-effectiveness of a universal strategy to promote physical activity in primary care".

scientific article published on 10 March 2015

Commentary to: Cost of poor adherence to anti-hypertensive therapy in five European countries

scientific article published on 28 July 2015

Comparing the validity of different measures of illness severity: a hospital-level analysis for acute myocardial infarction

scientific article published on 01 August 2012

Considering productivity loss in cost-effectiveness analysis: a new approach

scientific article published on 01 November 2014

Consumption costs and earnings during added years of life - a reply to Nyman

scientific article published on 01 March 2006

Convergence of decision rules for value-based pricing of new innovative drugs

scientific article published on 18 October 2014

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis

scientific article published on July 1, 2011

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

scientific article published on 01 February 2020

Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis

scientific article

Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women

scientific article published in January 2008

Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study

scientific article

Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia: A Systematic Review ⬇️

scientific article published on 02 February 2012

Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000.

scientific article published in September 2004

Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany

scientific article

Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands--a Markov model

scientific article

Cost-effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease

scientific article published in April 2011

Cost-effectiveness of cardioverter-defibrillators in heart failure patients

scientific article published on 31 October 2009

Cost-effectiveness of future lockdown policies against the COVID-19 pandemic

scientific article published in 2022

Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).

scientific article

Cost-effectiveness of preventing hip fractures by hip protectors in elderly institutionalized residents in Germany

scientific article published in December 2008

Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries

scientific article published in November 2006

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results

scientific article published on 02 October 2020

Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women

scientific article published on 10 August 2009

Costs and quality in the treatment of acute depression in primary care: a comparison between England, Germany and Switzerland

scientific article published on 01 July 2004

Costs of dialysis--a regional population-based analysis

scientific article published on 15 December 2009

Costs of patients with chronic kidney disease in Germany

scientific article published on 24 April 2020

Cost–effectiveness of preventing weight gain and obesity: what we know and what we need to know ⬇️

scientific article published on June 1, 2012

Defining Comparators According to IQWiG's Efficiency-Frontier Method

scientific article published on 04 April 2020

Depression and health-related quality of life

scientific article

Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor

scientific article published on 20 December 2013

Direct costs of care in germany for children and adolescents with diabetes mellitus in the early course after onset

scientific article published in November 2004

Does prevention save costs?

scientific article published on 20 March 2005

Drug pricing and control of health expenditures: a comparison between a proportional decision rule and a cost-per-QALY rule

scientific article published on May 2014

Economic analysis of influenza vaccination and treatment

Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults

scientific article published in January 2009

Economic evaluations alongside equivalence and noninferiority trials

scientific article published on 12 January 2009

Educating authors and reviewers of economic evaluations of health care

scientific article published on 01 August 2002

Educational epidemiology

Empirical validation of patient versus population preferences in calculating QALYs

scientific article published on 21 April 2011

Ethical criteria for allocating health-care resources

scientific article published in The Lancet

Ethical objections against including life-extension costs in cost-effectiveness analysis: a consistent approach

scientific article published in October 2014

European comparison of costs and quality in the treatment of acute back pain

scientific article

Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules

scientific article published in March 2011

Health care expenditures from living longer--how much do they matter

scientific article published on 18 February 2013

How much does it cost to change the behavior of health professionals? A mathematical model and an application to academic detailing

scientific article published in May 2005

Impact of demographic changes on healthcare expenditures and funding in the EU.

scientific article published on January 2005

Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses

scientific article published on 20 May 2014

Improving communication of health-related quality of life

scientific article published on 01 April 2003

Incorporating feelings related to the uncertainty about future health in utility measurement

scientific article published on October 2008

Inductive reasoning in medicine: lessons from Carl Gustav Hempel's 'inductive-statistical' model

scientific article

Informing patients of their coronary risk

scientific article published on 01 August 2008

Internal validation of models with several interventions ⬇️

scientific article published on November 3, 2012

Investment in quality improvement: how to maximize the return

scientific article published in January 2010

Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?

scientific article published on 01 October 2016

Loss aversion and cost effectiveness of healthcare programmes

scientific article published on 01 January 2008

Modifiable behavioral factors as causes of death

scientific article published on 01 June 2004

Osteoporosis in German men: a cost-of-illness study

scientific article published on 11 December 2014

Patient preferences: a Trojan horse for evidence-based medicine?

scientific article published on 01 January 2018

Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy

article

Pharmaceutical risk-sharing agreements

scientific article published on 01 January 2009

Predictors of negotiated prices for new drugs in Germany

scientific article published on 25 May 2020

Presenting Germany's drug pricing rule as a cost-per-QALY rule

scientific article published on 21 December 2011

Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?

scientific article published on 01 July 2011

Prioritizing health services research: an economic perspective

scientific article published on 05 February 2016

Productivity Loss Due to Irritable Bowel Syndrome

scientific article published on October 13, 2003

Protocol-driven costs in trial-based pharmacoeconomic analyses

scientific article published on December 2011

Reference pricing and price negotiations for innovative new drugs : viable policies in the long term?

scientific article

Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany

scientific article published on 01 October 2018

Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation

scientific article published on 15 February 2015

Simplifying rules for optimal allocation of preventive care resources ⬇️

scientific article published on April 1, 2012

Substantial treatment overuse in the United States?

scientific article published on 01 May 2007

Survivor costs in cost-effectiveness analysis

scientific article

Technology assessment in dentistry: a comparison of the longevity and cost-effectiveness of inlays

scientific article published in January 2005

The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany

scientific article published on 19 May 2020

The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany

scientific article published on 14 October 2020

The German method for setting ceiling prices for drugs: in some cases less data are required

scientific article

The additive utility assumption of the QALY model revisited

scientific article published on 11 November 2009

The economic value of medical technology

scientific article published on 01 January 2002

The ethics of non-inferiority trials

The practice-makes-perfect hypothesis in the context of other production concepts in health care

scientific article published in July 2003

Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs

scientific article published on 28 May 2010

Threshold volumes associated with higher survival in health care: a systematic review

scientific article published in October 2003

To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease - a Dutch perspective

scientific article published on 6 May 2013

Trends in rates of orthopedic surgery in Germany: the good, the bad, and the ugly

scientific article published on 11 November 2019

Underuse of innovative medicines in Germany: A justification for government intervention?

article

Utilitarian theories reconsidered: common misconceptions, more recent developments, and health policy implications

scientific article published on September 2003

Validation of models that estimate the cost-effectiveness of improving patient adherence

scientific article

Welfare gains and losses caused by clinical practice guidelines

scientific article published on 16 December 2013

What drives US competitiveness in mathematics and science?

When is it worth introducing a quality improvement program? A mathematical model

scientific article published in November 2003

When is it worth reducing overuse of health care services? The example of prescribing expensive antihypertensives

scientific article published in September 2005

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG

scientific article published on 22 April 2020

[Cost-effectiveness of quality improvement measures in health care]

scientific article published on 01 August 2002

Paulina is supported by:

About Paulina

Help